Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases
- PMID: 23012250
- PMCID: PMC4120666
- DOI: 10.1002/bies.201200099
Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases
Abstract
The intensity and prevalence of viral infections are typically higher in males, whereas disease outcome can be worse for females. Females mount higher innate and adaptive immune responses than males, which can result in faster clearance of viruses, but also contributes to increased development of immunopathology. In response to viral vaccines, females mount higher antibody responses and experience more adverse reactions than males. The efficacy of antiviral drugs at reducing viral load differs between the sexes, and the adverse reactions to antiviral drugs are typically greater in females than males. Several variables should be considered when evaluating male/female differences in responses to viral infection and treatment: these include hormones, genes, and gender-specific factors related to access to, and compliance with, treatment. Knowledge that the sexes differ in their responses to viruses and to treatments for viral diseases should influence the recommended course of action differently for males and females. Editor's suggested further reading in BioEssays X-chromosome-located microRNAs in immunity: Might they explain male/female differences Abstract.
Copyright © 2012 WILEY Periodicals, Inc.
Conflict of interest statement
No conflict of interest declared.
Figures
Similar articles
-
Sex differences in prophylaxis and therapeutic treatments for viral diseases.Handb Exp Pharmacol. 2012;(214):499-522. doi: 10.1007/978-3-642-30726-3_22. Handb Exp Pharmacol. 2012. PMID: 23027464 Review.
-
Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses?Front Immunol. 2018 Oct 8;9:2302. doi: 10.3389/fimmu.2018.02302. eCollection 2018. Front Immunol. 2018. PMID: 30349537 Free PMC article. Review.
-
Drugs for non-HIV viral infections.Treat Guidel Med Lett. 2005 Apr;3(32):23-32. Treat Guidel Med Lett. 2005. PMID: 15767977 No abstract available.
-
Antiviral prophylaxis and treatment (excluding HIV therapy).J Clin Virol. 2002 Dec;25(3):241-66. doi: 10.1016/s1386-6532(02)00151-8. J Clin Virol. 2002. PMID: 12423690 Review. No abstract available.
-
Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.Semin Immunopathol. 2019 Mar;41(2):203-211. doi: 10.1007/s00281-018-0727-4. Epub 2018 Nov 29. Semin Immunopathol. 2019. PMID: 30498927 Review.
Cited by
-
Independent effects of testosterone, estradiol, and sex chromosomes on gene expression in immune cells of trans- and cisgender individuals.bioRxiv [Preprint]. 2024 Oct 9:2024.10.08.617275. doi: 10.1101/2024.10.08.617275. bioRxiv. 2024. PMID: 39416170 Free PMC article. Preprint.
-
Comparative study on the epidemiological characteristics and hazards of respiratory syncytial virus and influenza virus infections among elderly people.BMC Infect Dis. 2024 Oct 9;24(1):1129. doi: 10.1186/s12879-024-10048-1. BMC Infect Dis. 2024. PMID: 39385082 Free PMC article.
-
Recommendations for the Application of Sex and Gender Medicine in Preclinical, Epidemiological and Clinical Research.J Pers Med. 2024 Aug 27;14(9):908. doi: 10.3390/jpm14090908. J Pers Med. 2024. PMID: 39338162 Free PMC article. Review.
-
Differential pathogenicity and lethality of bubonic plague (1720-1945) by sex, age and place.Proc Biol Sci. 2024 Aug;291(2027):20240724. doi: 10.1098/rspb.2024.0724. Epub 2024 Jul 24. Proc Biol Sci. 2024. PMID: 39045692 Free PMC article.
-
Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection.Cent Eur J Immunol. 2024;49(1):11-18. doi: 10.5114/ceji.2024.135462. Epub 2024 Feb 17. Cent Eur J Immunol. 2024. PMID: 38812601 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical